Abstract
Introduction: Topiramate is a well-known anticonvulsant drug with a broad spectrum of actions. It has been proposed in the treatment of several types of epileptic seizures both in monotherapy and in add-on. Its usage has been extended to other disorders including migraine, essential tremor, obesity, alcohol and drug addiction.
The most frequent side-effects of topiramate include dizziness, somnolence, insomnia, and ataxia. Paraesthesia, metabolic acidosis, kidney stones, hypohidrosis, cognitive impairment and eye symptoms have also been reported.
Case Report: We report on a girl affected by epileptic seizures treated with levetiracetam for five years. Due to worsening of the seizures, the dosage of this drug was increased and afterwards lowdosage topiramate was initiated. After 12 days from the introduction of topiramate, the girl began to present neurologic signs including limbs rigidity, pain, incoordination and flexed fingers. Gradual withdrawn of the topiramate resulted in progressive resolution of the symptomatology. This clinical episode could represent a probable topiramate-related side effect (Naranjo score 5), never reported before in this form.
Keywords: Topiramate, levetiracetam, side-effect, paraesthesia, rigid flexion, naranjo score.
Graphical Abstract
Current Drug Safety
Title:A Probable Topiramate-induced Limbs Paraesthesia and Rigid Fingers Flexion
Volume: 13 Issue: 2
Author(s): Andrea Domenico Pratico*, Martino Ruggieri, Raffaele Falsaperla and Piero Pavone
Affiliation:
- Section of Pediatrics and Child Neuropsychiatry, Department of Clinical and Experimental Medicine, Univesity of Catania, Catania,Italy
Keywords: Topiramate, levetiracetam, side-effect, paraesthesia, rigid flexion, naranjo score.
Abstract: Introduction: Topiramate is a well-known anticonvulsant drug with a broad spectrum of actions. It has been proposed in the treatment of several types of epileptic seizures both in monotherapy and in add-on. Its usage has been extended to other disorders including migraine, essential tremor, obesity, alcohol and drug addiction.
The most frequent side-effects of topiramate include dizziness, somnolence, insomnia, and ataxia. Paraesthesia, metabolic acidosis, kidney stones, hypohidrosis, cognitive impairment and eye symptoms have also been reported.
Case Report: We report on a girl affected by epileptic seizures treated with levetiracetam for five years. Due to worsening of the seizures, the dosage of this drug was increased and afterwards lowdosage topiramate was initiated. After 12 days from the introduction of topiramate, the girl began to present neurologic signs including limbs rigidity, pain, incoordination and flexed fingers. Gradual withdrawn of the topiramate resulted in progressive resolution of the symptomatology. This clinical episode could represent a probable topiramate-related side effect (Naranjo score 5), never reported before in this form.
Export Options
About this article
Cite this article as:
Pratico Domenico Andrea *, Ruggieri Martino, Falsaperla Raffaele and Pavone Piero , A Probable Topiramate-induced Limbs Paraesthesia and Rigid Fingers Flexion, Current Drug Safety 2018; 13 (2) . https://dx.doi.org/10.2174/1574886313666180213090445
DOI https://dx.doi.org/10.2174/1574886313666180213090445 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Perspectives of Medieval Persian Medicine on Multiple Sclerosis
Current Drug Metabolism Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies
Current Neuropharmacology An Approach to the Rational Design of Opioid Receptor Ligands Non-narcotic k-Opioid Receptor Ligand KT-95 Free from Euphoria and or Dysphoria
Current Medicinal Chemistry - Central Nervous System Agents Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene
Current Genomics The Possible Adverse Effects of Intramuscular Botulinum Toxin Injections and their Management
Current Drug Safety Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2
Current Protein & Peptide Science The Oxygen Therapy
Current Medicinal Chemistry Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
Current Drug Targets N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research Duloxetine in the Treatment of Depression: An Overview
Central Nervous System Agents in Medicinal Chemistry Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Current Drug Therapy Concepts for Biologically Active Peptides
Current Pharmaceutical Design “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds Lithium in Psychiatry-The Benefits and Risks Associated with the Lithium Salts Treatment in Affective Disorders
Current Psychopharmacology Bridging Over the Troubled Heterogeneity of SPG-Related Pathologies: Mechanisms Unite What Genetics Divide
Current Molecular Medicine Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Mitochondrial Biology and Neurological Diseases
Current Neuropharmacology